Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...

Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

April 06, 2026) Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich ...

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

Scientists are uncovering a surprising connection between autism and ADHD that goes deeper than labels. Instead of diagnoses, it’s the severity of autism-like traits that seems to shape how the brain ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced an oral presentation at the United States and Canadian Academy of Pathology (USCAP) 115th Annual ...

Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the ...

Scientists mapped the maternal–fetal interface revealing new cell types, genetic links, and mechanisms behind pregnancy complications.

A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company UP Oncolytics showed encouraging preclinical results in two studies presented at the American ...